MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms

Dean W Felsher1

  • 1Division of Oncology, Departments of Medicine and Pathology, Stanford University, Stanford, CA, USA.

Genes & Cancer
|November 2, 2010
PubMed

Insights

Inactivating the MYC oncogene shows promise as a cancer therapy. This approach leverages oncogene addiction to induce tumor regression across various cancer types.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Tumorigenesis often involves genetic alterations activating oncogenes or deactivating tumor suppressor genes.
  • Oncogene addiction describes tumor regression following targeted inactivation of activated oncogenes.
  • MYC oncogene activation is a frequent event in human cancers.

Purpose of the Study:

  • To investigate the therapeutic potential of MYC oncogene inactivation in cancer treatment.
  • To explore the mechanisms underlying tumor regression induced by MYC inactivation.

Main Methods:

  • Experimental inactivation of the MYC oncogene in various cancer models.
  • Analysis of tumor regression and associated cellular and molecular changes.
  • Investigation of cell-autonomous and cell-dependent mechanisms, including autocrine factors.

Main Results:

  • MYC inactivation led to significant and sustained tumor regression in multiple cancer types (lymphoma, leukemia, osteosarcoma, etc.).
  • Mechanisms of regression include proliferative arrest, differentiation, senescence, apoptosis, and anti-angiogenesis.
  • Both cell-intrinsic and host-dependent pathways, involving factors like thrombospondin-1 and TGF-β, contribute to tumor regression.

Conclusions:

  • Targeting MYC inactivation represents a potential broad-spectrum cancer therapy.
  • This strategy exploits oncogene addiction, leading to tumor regression via diverse mechanisms.
  • Both tumor cell-autonomous and host-mediated responses are crucial for therapeutic efficacy.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...